[1]
“Beyond PD-1/PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance”, J Biomol Pathog Ther, vol. 2, no. 1, Mar. 2026, Accessed: Apr. 08, 2026. [Online]. Available: https://jbptjournal.org/index.php/jbpt/article/view/33